National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -10 of 381         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Biomarker/Laboratory analysis, Treatment


Active


18 to 75


Other


ASSO OE-1
EudraCT 2006-006647-31, NCT00525200


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Active


18 and over


Pharmaceutical / Industry


D7913C00046
NCT00536107


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Active


18 and over


Other


YUNZHI-BC
NCT00647075


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Approved-not yet active


18 and over


Pharmaceutical / Industry


ML21343
NCT00774241


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Active


18 and over


Pharmaceutical / Industry


simcere002
simcere0802, NCT00813332

Last Modified: 4/29/2008     First Published: 12/16/2005  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


Not specified


Other


MRC-STAMPEDE
EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476


7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Supportive care, Treatment


Active


17 to 75


Pharmaceutical / Industry


PH-CP010
NCT00518869

Last Modified: 11/13/2008     First Published: 9/1/2001  

8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Any age


NCI


MDA-ID-00156
NCI-3410, 3410, NCT00024167

Last Modified: 12/4/2008     First Published: 2/1/2002  

9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Biomarker/Laboratory analysis, Treatment


Active


18 to 75


Other


SWS-SAKK-16/00
EU-20138, NCT00030771

Last Modified: 5/27/2008     First Published: 7/1/2002  

10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Pharmaceutical / Industry


INTROGEN-T302
UCLA-0312111-01, NCT00041626

   
    1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov